Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03069729 · ClinicalTrials.gov registry record
Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)
A clinical trial of Diabetic Retinopathy and Diabetic Foot, sponsored by VisionQuest Biomedical.
- Completed
- Registry status
- 331
- Enrollment target
- 1
- Study location
NCT03069729: Completed study of Diabetic Retinopathy and Diabetic Foot, sponsored by VisionQuest Biomedical.
NCT03069729 is a study of Diabetic Retinopathy and Diabetic Foot that has completed, run by VisionQuest Biomedical. The registered enrollment target is 331 participants, below the 1,671-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03069729, a study of Diabetic Retinopathy and Diabetic Foot, has completed, sponsored by VisionQuest Biomedical.
- COMPLETED
- Registry status
- 331 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research is to develop better tools for diagnosing illness of the feet and legs of people who have diabetes. Investigators will use thermal videos of the foot to aid in the refinement of a system designed to detect signs of diabetic peripheral neuropathy (DPN). The team of investigators will also look at diabetic eye disease and how it might relate to diabetic foot disease.
Primary Outcome
The thermal recovery pattern after cold provocation will be different for each group studied.
Conditions Studied
Interventions
- OTHER no intervention
Study Locations (1)
New Mexico
- VisionQuest Biomedical LLC - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 331 participants |
| Start Date | 2017-03-08 |
| Est. Completion | 2019-09-01 |
What the finished NCT03069729 record still lists
NCT03069729 is an observational study that tracks outcomes without assigning an intervention. The registered 331 participants enrollment target is mid-sized for trials with a published cap, below the 1,671-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with Diabetic Retinopathy appearing as the primary indexed condition, and to 1 intervention - of which no intervention is the first listed.
NCT03069729 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT03069729 about?
NCT03069729 is a clinical study titled "Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)". The goal of this research is to develop better tools for diagnosing illness of the feet and legs of people who have diabetes. Investigators will use thermal videos of the foot to aid in the refinement of a system designed to detect signs of diabetic peripheral neuropathy (DPN). The team of investiga...
What is the current status of trial NCT03069729?
This trial is currently completed. The enrollment target is 331 participants. The study started on 2017-03-08. Estimated completion is 2019-09-01.
What conditions does trial NCT03069729 study?
This clinical trial studies the following conditions: Diabetic Retinopathy, Diabetic Foot, Diabetic Neuropathies.
What interventions are being tested in trial NCT03069729?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT03069729?
This trial is sponsored by VisionQuest Biomedical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03069729 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03069729's enrollment target sits among peer trials
331 20th of 57 higher than 38 of 57 other Diabetic Retinopathy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Retinopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fenofibrate for Prevention of DR Worsening
RECRUITING · Phase 3
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
RECRUITING
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
RECRUITING · Phase 2
-
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI